The Rise of mRNA: From COVID Vaccines to Personalized Cancer Treatment

mRNA technology, proven by COVID vaccines (Pfizer/BioNTech, Moderna), is expanding into cancer treatment. Moderna's personalized cancer vaccine (mRNA-4157) showed 44% reduction in melanoma recurrence in Phase II trials combined with Keytruda. BioNTech developing individualized neoantigen therapies. The platform advantage: mRNA can be designed and manufactured in weeks for any protein target. Beyond cancer: flu, RSV, HIV, Zika, and rare genetic diseases in clinical trials. The mRNA revolution is creating a new era of rapid-response medicine.